Skip to main content

HCMC Announces Publishing of an Independent Report Regarding the Use of Arecoline as a Possible Preventative for Covid19. HCMC Owns U.S. Patent Covering Processes and Methods of Manufacture of Arecoline 

Written by Customer Service on . Posted in Public Companies.

HOLLYWOOD, FL, April 03, 2020 (GLOBE NEWSWIRE) — Healthier Choices Management Corp. (OTC Pink: HCMC) announced today that On March 31, 2020, an independent report created by the NuTrade LLC Corona Virus Task Force was published. This report reviews the possibility of the use of Arecoline, a nicotinic acid-based alkaloid, as a possible preventative for COVID-19.
HCMC owns a United States Patent, which covers, among other things, the methods of manufacture of Arecoline, which is derived from the Areca nut.
HCMC is actively reviewing the report and seeking possible ways to monetize its intellectual property.NuTrade LLC is currently engaged as a consultant by HCMC and has an economic interest in the aforementioned patent, as well as several other patents owned by the Company.The link to the report is www.arecolinereport.com HCMC has not independently verified any information or findings contained in the report.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.